Ye Lan, Schnegelsberg Margret, Obermann Mark
Department of Neurology, Asklepios Hospitals Schildautal, Seesen, Germany.
Proc (Bayl Univ Med Cent). 2020 Sep 28;34(1):114-115. doi: 10.1080/08998280.2020.1822132.
This case describes a middle-aged man with anti-dipeptidyl-peptidase-like protein 6 (DPPX) encephalitis who exhibited the triad of memory loss, diarrhea, and tremor. The progression of his disease resembled neurodegenerative disease, and his first presentation at our department was 2 years after the first onset of symptoms. Antibodies against DPPX were positive in both serum and cerebrospinal fluid. No related tumor was found. The patient was initially treated with corticosteroid therapy and plasmapheresis. Despite moderate response to this treatment, corticosteroids were ceased because of adverse effects such as Cushing syndrome, deep vein thrombosis, and osteoporosis. After five cycles of treatment with rituximab, the patient experienced no further progression of neurologic symptoms and no adverse effects. The case adds to the understanding of the diagnosis, treatment, and potential prognosis of anti-DPPX encephalitis.
本病例描述了一名患有抗二肽基肽酶样蛋白6(DPPX)脑炎的中年男性,他表现出失忆、腹泻和震颤三联征。其疾病进展类似于神经退行性疾病,他首次到我院就诊是在症状首次出现2年后。血清和脑脊液中抗DPPX抗体均呈阳性。未发现相关肿瘤。患者最初接受了糖皮质激素治疗和血浆置换。尽管对此治疗有中度反应,但由于出现库欣综合征、深静脉血栓形成和骨质疏松等不良反应,糖皮质激素治疗被停用。在用利妥昔单抗治疗五个周期后,患者神经症状未进一步进展,也未出现不良反应。该病例有助于加深对抗DPPX脑炎的诊断、治疗及潜在预后的理解。